http://bidug.pnl.gov/references/wsrc-mm-2000-00097.pdf

   WSRC-MM-2000-00097 August 8, 2000 The New ICRP Respiratory Tract And
   Systemic Models Thomas R. La Bone Westinghouse Savannah River Company
   Savannah River Site Aiken, SC 29808 The New ICRP Respiratory Tract and
   Systemic Models Thomas R. La Bone Westinghouse Savannah River Company
   Savannah River Site Aiken, SC 29808 WSRC-MM-2000-00097 August 8, 2000 1
   Overview * Review respiratory tract models  ICRP 66  ICRP 30  ICRP 2
   NCRP 125 * Benchmark ICRP 66 respiratory tract model * Review systemic
   models  ICRP 2  ICRP 30  ICRP 56 series * Benchmark ICRP 66/67 Pu-239
   model * Discuss practical applications of the new ICRP models 2
   Characteristics of All Four Lung Models * Anatomy and Physiology *
   Deposition * Clearance * Dosimetry To some extent, all models are wrong
   3 ICRP 2 * Issued in 1959 in ICRP 2, "Permissible Dose for Internal
   Dosimetry" * Designed for deriving secondary limits for adult radiation
   workers 4 Deposition and Clearance 0.500 0.125 0.125 Upper Lower Lower
   Respiratory Respiratory Respiratory Tract Tract Tract a b 120 day
   within immediately halflife 24 hours Stomach Blood Stomach 5 Lung
   Dosimetry Lung E = E - g f ( s x 1- e ) 10 cm 6 Limitations of Model *
   Does not define the anatomy of the respiratory tract * Does not fully
   define the kinetics of lung clearance * Does not address the dependence
   of clearance on the solubility of the material * Does not address the
   dependence of deposition on particle size * Does not address cross fire
   from other source organs * Treats the lung as a single 1000-gram organ
   7 However The ICRP 2 lung model was used to derive Maximum Permissible
   Concentrations (MPCs) for air that were used with great success to
   protect radiation workers for over 30 years. 8 ICRP 30 * Issued in 1978
   in ICRP 30, "Limits for Intakes of Radionuclides by Workers" * Designed
   for deriving secondary limits for adult radiation workers * Based on
   the 1966 report of the Task Group on Lung Dynamics * Designed to
   improve on ICRP 2 model while retaining its simplicity  Deposition
   model accounts for aerosol size  Clearance model addresses solubility
   Completely defined kinetics 9 Anatomy and Physiology * nasal passage
   (NP region) * trachea and bronchial tree (TB region) * pulmonary
   parenchyma (P region) 10 Lung Deposition * Deposition in each of the
   regions depends on the activity median aerodynamic diameter (AMAD) of
   the aerosol 1 µm 1 µm aerodynamic sphere diameter particle 11
   Deposition Model 99.999% 99.99% 99.9% 99% NP 90% P 70% 50% 30%
   Deposition 10% TB 1% 0.1% 0.01% 0.001% 10-1.0 2 3 4 5 6 7 100.0 2 3 4 5
   6 7 101.0 2 Particle Size (microns) 12 Default Deposition * Aerosol
   AMAD of 1 µµm is assumed for occupational exposures  Deposition in the
   NP region DNP is 0.30 of the inhaled aerosol  Deposition in the TB
   region DTB is 0.08 of the inhaled aerosol  Deposition in the P region
   DP is 0.25 of the inhaled aerosol  Total deposition is 0.63 of the
   inhaled aerosol 13 Clearance Model a NP b S blood c TB d e f i P lymph
   h g j 14 Lung Clearance Classes * Class D - cleared from P region in
   less than 10 days (0.5 day default) * Class W - cleared from the P
   region in less than 100 days but more then 10 days (50 day default) *
   Class Y - cleared from the P region in more than 100 days (500 day
   default) 15 Model Parameters for Class Y Material Halflife Compartment
   (days) Fraction a 0.01 0.01 b 0.4 0.99 c 0.01 0.01 d 0.2 0.99 e 500
   0.05 f 1 0.4 g 500 0.4 h 500 0.15 I 1000 0.9 j 1.00E+10 0.1 16 System
   of ODEs dNa = IDNP fa -kaNa dt dNb = IDNP fb -kbNb dt dNc = IDNP fc
   -kcNc dt 17 Solving ODEs * Laplace transforms * Recursive algebraic
   solutions (Skrable's Dragon) * Numerical ODE solvers  MathCad
   Mathematica  Maple * MathCad example for Pu-239 18 Dose Equivalent HT =
   c Us,j ( SEE T S)j s j 19 Specific Effective Energy SEE(T S) R Q ER R Y
   AF(T S) = R R MT SEE(lung lung) = ( 6. 1 ×10 10 - )(20)( 15 . 5 MeV)
   1000g SEE lung ( lung) = 648 . 1 ×10 11 - Sv/ decay 20 SEE, Decays, and
   Dose LaBone ICRP 30 SEE (Sv/decay) 1.648E-11 1.6E-11 Decays 1.925E+07
   1.9E+07 Lung DE (Sv) 3.172E-04 3.0E-04 Lung DE is listed in ICRP 30 as
   3.2E-4 Sv/Bq 21 Effective Dose Equivalent He = iwHi i Weighting factor
   for the lung is 0.12 22 Limitations of Model * Lung is a single
   1000-gram organ * Ignores dose to NP region * Conservative model
   designed for adult radiation workers * Not designed for evaluating
   bioassay data 23 NCRP 125 * Issued in 1997 in NCRP 125, "Deposition,
   Retention and Dosimetry of Inhaled Radioactive Substances" * Different
   than the ICRP 66 model * Recommends the use of ICRP 66 model for
   radiation protection * Uses non-linear kinetics * Not intended for
   interpretation of bioassay data 24 ICRP 66 * Issued in 1994 in ICRP 66,
   "Human Respiratory Tract Model for Radiological Protection" 25 Goals of
   ICRP 66 * "provide a realistic framework for modeling lung retention
   and excretion characteristics in an individual case, and the resulting
   lung and systemic organ doses, based on bioassay data; * take account
   of factors such as cigarette smoking and lung disease which influence
   lung retention; * enable knowledge of the dissolution and absorption
   behavior of specific materials to be used in the calculation of lung
   dose, systemic absorption and excretion; 26 * apply explicitly to all
   members of the population, giving reference values for children aged 3
   months, 1, 5, 10, and 15 years, and for adults; * apply to gases and
   vapors as well as particulates, and in all cases; * calculate
   biologically meaningful doses in a manner that is consistent with the
   morphological, physiological, and radiobiological characteristics of
   the various tissues of the respiratory tract." A. C. James ICRP Task
   Group on Lung Model 27 ICRP 66 Lung Model åAnatomy and physiology
   çDeposition éClearance èDosimetry 28 å åAnatomy and Physiology
   Extrathoracic Region * ET1 - anterior nose * ET2 - posterior nose,
   mouth, pharynx, larynx * NP region in ICRP 30 Model 29 Thoracic Region
   * Bronchial region (0-8)  BB or BBi * Bronchiolar region (9-15)  bb or
   bbe  TB region (with BB) in ICRP 30 model * Alveolar-interstitial
   region (16-26)  AI  P region in ICRP 30 model 30 31 Physiology * Tidal
   volume VT  inhale-exhale volume  1250 mL for light exercise  750 mL for
   sitting * Functional residual capacity FRC  volume left on exhale  3301
   mL * Anatomical dead space  volume of airways that do not exchange
   gases  146 mL * volumetric flow rate  twice breathing rate  833
   mL/second for light exercise  300 mL/second for sitting 32 ç
   çDeposition * Deposition model is empirical * Applicable to 0.0005 µµm
   to 100 µµm AMAD aerosols * Takes into account  physical exertion
   gender  age  ethnic origin  body size * Can give ranges for regional
   deposition * Quite complex 33 Series of Filters PF ET1 ET2 BB bb AI
   Inhale 0 1 2 3 4 5 Exhale 6 9 8 7 ET1 ET2 BB bb 34 Characteristics of
   Filters Each filter has * a filtration efficiency, (eta) * a volume, v
   function of physiological parameters 35 Deposition Processes Particles
   are caused to impinge on the surfaces of the respiratory tract by two
   different processes: * aerodynamic  particles carried by airflow
   dominate with larger particles (>1 µµm)  characterized by aerodynamic
   equivalent diameter, dae * thermodynamic  particles moved by Brownian
   motion  dominate with smaller particles (<0.1 µµm)  characterized by
   thermodynamic diameter, dth 36 Dual Properties All particles have both
   aerodynamic and thermodynamic properties. For example, for a 5 µµm dae
   aerosol 5mmdae = 35.mmdth 37 Filtration Efficiency h = input - output
   input input output 38 Calculating The filtration efficiency is
   calculated using empirical equations like the one shown below: h = - -
   1 e aR p where a, R, and p are parameters supplied in ICRP 66. 39 th
   for 5 µµm dae aerosol Filter Region a R p 1 ET1 18.0000 1.343E-08
   0.5000 0.0010 2 ET2 15.1000 1.343E-08 0.5380 0.0009 3 BB 60.1773
   5.049E-09 0.6391 0.0003 4 bb 90.2000 4.833E-09 0.5676 0.0017 5 AI
   273.0000 9.247E-08 0.6101 0.0139 6 bb 90.2000 4.833E-09 0.5676 0.0017 7
   BB 60.1773 5.049E-09 0.6391 0.0003 8 ET2 15.1000 1.343E-08 0.5380
   0.0009 9 ET1 18.0000 1.343E-08 0.5000 0.0010 40 ae for 5 µµm dae
   aerosol Filter Region a R p 1 ET1 3.000E-04 2.083E+04 1.0000 0.4310 2
   ET2 5.500E-05 2.083E+04 1.1700 0.8613 3 BB 4.080E-06 2.083E+04 1.1520
   0.3197 4 bb 1.147E-01 1.735E+00 1.1730 0.1966 5 AI 1.460E-01 3.205E+01
   0.6495 0.7504 6 bb 1.147E-01 1.735E+00 1.1730 0.1966 7 BB 2.040E-06
   2.083E+04 1.1520 0.1752 8 ET2 5.500E-05 2.083E+04 1.1700 0.8613 9 ET1
   3.000E-04 2.083E+04 1.0000 0.4310 41 Total Filtration Efficiency 11 / h
   2 2 1 2 1 = (hae +hth ) / h 2 2 1 2 1 = (0 4310 . + 0 0010 . ) h1 = 0
   4310 . 42 Prefilter * The nasal opening is a prefilter having no volume
   and a filtration efficiency of 0 * The prefilter filtration efficiency
   is the complement of the inhalability I * Inhalability is the ratio of
   the concentration CI of particles in inspired air to the concentration
   CA of particles in ambient air h CI I = CA h 1 0 = - hI 43 Total
   Filtration Efficiency For a monodisperse aerosol with an aerodynamic
   equivalent diameter (dae) of 5 µµm, the filtration efficiencies are: .
   3.221 10 2 0.7506 0 5 0.4310 0.1966 1 6 0.8613 0.1752 2 7 0.8613 0.3197
   8 3 0.1966 0.4310 4 9 44 Filter Volume for Light Exercise v 0 v . 47 1
   1250 v v 0 4 3301 7 3 v 0 v v 1 v = 64.798 8 2 4 v 50 2 v 1250 v v 5 9
   1 v . 49 1 1250 3 3301 v v 6 4 v = 67.555 3 45 Volumetric fraction f0 =
   1 k 1 - v i f i=0 k = 1- ,k = 1to5 T V fk = f10-k ,k =6to9 46 1 1 9 1 1
   2 8 2 v 1 2 = 0.96 3 V 3 7 3 T v v 1 2 3 = 0.906 4 V 4 6 4 T v v v 1 2
   3 4 = 0.854 5 V 5 T 47 Deposition Fraction i-1 i DE =hi fi (1-hk ) k =0
   48 DE . 1 1 1 0 DE = 1 4.171 10 1 DE . . 2 2 1 0 1 1 DE = 2 4.743 10 1
   v DE 1 2 . . . . 3 DE V 3 1 0 1 1 1 2 = 3 2.344 10 2 T v DE . 2 v3 . 1
   . . . 4 4 1 DE V 0 1 1 1 2 1 3 = 4 9.255 10 3 T v DE . 2 v3 v4 . 1 . .
   . . 5 5 1 DE V 0 1 1 1 2 1 3 1 4 = 5 2.676 10 2 T 49 v DE . 2 v3 v4 . 1
   . . . . 5 5 1 DE V 0 1 1 1 2 1 3 1 4 = 5 2.676 10 2 T v DE . 2 v3 . 1 .
   . . . . 6 6 1 DE V 0 1 1 1 2 1 3 1 4 1 5 = 6 1.854 10 3 T v DE . 2 . 1
   . . . . . . 7 7 1 DE V 0 1 1 1 2 1 3 1 4 1 5 1 6 = 7 1.407 10 3 T DE .
   1 . . . . . . . 8 8 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 DE = 8 5.942 10 3 DE
   . 1 . . . . . . . . 9 9 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 DE = 9 4.124
   10 4 50 Recursive Form Given x fi , then i = fi-1 DE . 1 1 1 0 DE = 1
   4.171 10 1 DE DE . . . 1 2 1 2 2 1 DE = 2 4.743 10 1 1 DE DE . . . 1 3
   2 3 3 1 DE = 3 2.344 10 2 2 DE DE . . . 1 4 3 4 4 1 DE = 4 9.255 10 3 3
   51 DE DE . . . 1 1 DE = 2.676 10 2 5 4 5 5 5 4 DE DE . . . 1 1 DE =
   1.854 10 3 6 5 6 6 6 5 DE DE . . . 1 1 DE = 1.407 10 3 7 6 7 7 7 6 DE
   DE . . . 1 1 8 7 8 8 DE = 5.942 10 3 7 8 DE DE . . . 1 1 DE = 4.124 10
   4 9 8 9 9 9 8 52 Total Deposition for Light Exercise D et1 DE1 DE9 D =
   et1 4.175 10 1 D et2 DE2 DE8 D = et2 4.802 10 1 D BB DE3 DE7 D = BB
   2.485 10 2 D bb DE4 DE6 D = bb 1.111 10 2 D ai DE5 D = ai 2.676 10 2 D
   D et1 D et2 D BB D bb D ai D = 9.605 10 1 53 Slow Clearing Fraction for
   BB and bb r fs = 5 . 0 , dae 5 . 2 c 0.693 - (dt - .25) 1 1 . r fs = 5
   . 0 e , dae > 5 . 2 c is the density of the particle and is the shape
   factor 54 Slow Clearing Fraction for 5 µµm dae particle - ln(2)
   (3.5-2.5) f 1.1 s = 0.5 e fs = 0.266 55 Lognormal Probability Density
   Function f(x) gives the differential fraction of particles between dae
   x and x + dx -[Ln(x )-Ln(mg )]2 [2Ln(sg )2] f ( ) e x = xLn(s g ) p 2
   56 Lognormal PDF 0.12 g = 2.5 0.1 AMAD = µµg = 5.0 0.08 0.06 Fraction
   0.04 0.02 20 40 60 80 Aerodynamic equivalent diameter (µµm) 57
   Lognormal Cumulative Probability Function F(X) gives the probability of
   observing a particle the same size or smaller than X: X F(X ) = f (x)dx
   0 58 Deposition for Polydisperse Aerosol DE( max AMAD, d d s g )=
   DE(dae) ae ae F dae + - F dae - min 2 2 59 Range and Increments of
   Summation * Summation runs from min of -4 g to max of +4 g * dae is
   given by (max - min) / 500 0.12 0.1 0.08 Fraction 0.06 0.04 0.02 20 40
   60 80 Aerodynamic equivalent diameter (µµm) 60 Total Percent Deposition
   for 5 µµm AMAD Aerosol during Light Exercise Percent La Bone Ludep
   Error ICRP 66 ET1 34.77 34.80 -0.09 35.00 ET2 40.91 40.94 -0.07 41.00
   BB 1.80 1.80 0.00 1.82 bb 0.89 0.89 0.00 0.90 AI 4.49 4.49 0.00 4.50
   TOTAL 82.86 82.92 -0.07 83.00 FsBB 34.33 34.32 0.03 34.07 Fsbb 41.09
   41.07 0.05 41.11 61 Total Percent Deposition for 5 µµm AMAD Aerosol
   during Sitting Percent La Bone Ludep Error ICRP 66 ET1 28.08 28.10
   -0.07 28.00 ET2 33.58 33.61 -0.09 34.00 BB 1.62 1.63 -0.61 1.63 bb 2.37
   2.37 0.00 2.37 AI 10.38 10.40 -0.19 10.00 TOTAL 76.04 76.10 -0.08 76.00
   FsBB 26.75 26.73 0.07 26.38 62 Deposition Fractions for Light Work *
   Light Work consists of  5.5 hours of light exercise breathing at 1.5 m3
   per hour  2.5 hours of sitting, breathing at 0.54 m3 per hour * The
   deposition fractions for light work are the volume-weighted deposition
   fractions for the two activity levels 54 . 0 × 5 . 2 fsitting = × + × =
   54 . 0 5 . 2 5 . 1 5 . 5 14 . 0 5 . 1 × 5 . 5 fle = × + × = 54 . 0 5 .
   2 5 . 1 5 . 5 86 . 0 63 Total Percent Deposition for 5 µµm AMAD Aerosol
   during Light Work Percent La Bone Ludep Error ICRP CD ET1 33.83 33.85
   -0.06 33.85 ET2 39.88 39.91 -0.08 39.91 BB 1.77 1.77 0.00 1.78 bb 1.10
   1.10 0.00 1.10 AI 5.32 5.32 0.00 5.32 TOTAL 81.90 81.96 -0.07 81.96
   FsBB 33.26 33.34 -0.24 33.35 Fsbb 40.47 39.75 1.81 39.75 64 Additional
   Calculations * Other mixtures of breathing rates * breathing habits
   mouth breather during light exercise » 40% of air through nose » 60% of
   air through mouth * adjustments for age and sex * smokers and
   respiratory ailments 65 é éClearance * mechanical clearance of
   particles  to lymph nodes and GI tract  dependent on region of lung
   independent of material * absorption to blood  dependent on solubility
   of particles  F/M/S classification  same for all regions of lung
   (except ET1) * competitive processes * linear first order kinetics 66
   Mechanical Clearance ET1 Environment LN ET ET ET seq 2 GI BB BB BB seq
   2 1 bb bb seq 2 bb1 LNTH AI AI 3 2 AI1 67 Partition of Deposition
   Partition Compartment Fraction ET2 0.9995 ETseq 0.0005 BB1 0.993-FsBB
   BB2 FsBB BBseq 0.007 bb1 0.993-Fsbb bb2 Fsbb bbseq 0.007 AI1 0.3 AI2
   0.6 AI3 0.1 68 Mechanical Clearance Parameters Rate half-time Pathway
   (1/d) (d) AI1-bb1 0.02 3.47E+01 AI2-bb1 0.001 6.93E+02 AI3-bb1 0.0001
   6.93E+03 AI3-LNTH 0.00002 3.47E+04 bb1-BB1 2 3.47E-01 bb2-BB1 0.03
   2.31E+01 bbseq-LNTH 0.01 6.93E+01 BB1-ET2 10 6.93E-02 BB2-ET2 0.03
   2.31E+01 BBseq-LNTH 0.01 6.93E+01 ET2-GI 100 6.93E-03 ETseq-LNTH 0.001
   6.93E+02 ET1-Env 1 6.93E-01 69 Absorption into Blood s Particles in pt
   Particles in Initial State Transformed State fb sp f s b t (1-f (1-f )s
   b)sp b t Bound Material sb Blood 70 Time Dependant Dissolution Function
   -srt -sst r t() = f e + 1 ( - f ) e r r sp = ss + (sr - ss) fr spt =
   (sr - ss) 1 ( - fr ) t s = ss 71 Total Clearance AI1 bb1 transformed
   blood transformed AI1 bb1 bound bound AI bb 72 Solubility
   Classifications * ICRP 66  F, fast dissolution  M, moderate dissolution
    S, slow dissolution  refers to absorption to blood only * ICRP 30  D,
   cleared in days  W, cleared in weeks  Y, cleared in years  refers to
   total clearance (absorption and mechanical) 73 Absorption Parameters
   D/F W/M Y/S sp 100 10 0.1 spt 0 90 100 st na 0.005 0.0001 fb 0 0 0 74
   Gases and Vapors * No general deposition and clearance models as for
   aerosols * General classifications  Insoluble and non-reactive: SR-0 »
   H2, He, N2  soluble or reactive: SR-1 » O3, NO2, H2O  soluble and
   reactive: SR-2 » SO2, HF 75 è èDosimetry * ICRP 60 quantities
   equivalent dose (dose equivalent)  effective dose (effective dose
   equivalent) * Equivalent dose to target tissues  Nuclear
   transformations (decays) in source tissues  Specific effective energy
   (SEE) for all source-target tissue combinations  Cellular targets *
   Detriment weighted equivalent dose  radiation detriment apportionment
   factors * Effective dose  ICRP 60 weighting factors 76 Decays The
   number of decays of radionuclide j in source organ S over 50 years is
   given by 50 Us,j = qs,j (t)dt 0 77 Decay Benchmark for 5 µµm AMAD Class
   S Pu-239 (light work) Percent Compartment La Bone Ludep Error AI
   4621000 4600000 0.46 bb1 2323 2300 1.00 bb2 12570 13000 -3.31 bbseq 660
   660 0.00 BB1 603 600 0.50 BB2 16980 17000 -0.12 BBseq 1062 1100 -3.45
   ET1 29250 29000 0.86 ET2 410 410 0.00 ETseq 15660 16000 -2.13 LNET
   128800 130000 -0.92 LNTH 444200 440000 0.95 78 Sources * ET1-sur (ET1)
   * ET2-sur (ET2 + TET2) * ET2-seq (ETseq + TETseq) * LN-ET (LNET +
   TLNET) * BB-gel (BB1 + TBB1) * BB-sol (BB2 + TBB2) * BB-seq (BBseq +
   TBBseq) * bb-gel (bb1 + Tbb1) * bb-sol (bb2 + Tbb2) * bb-seq (bbseq +
   Tbbseq) * AI (AI1 + AI2 + AI3 + TAI1 +TAI2 + TAI3) * LN-TH (LNTH +
   TLNTH) 79 Specific Effective Energy SEE(T S;t) R w ER R Y AF(T S;t) = R
   R MT (t) 80 Targets * ET1-bas * ET2-bas * LN-ET * BBi-bas * BBi-sec *
   bbe-sec * AI * LN-TH 81 82 83 SEE, decays, and HT for Pu-239 S E E
   Sources Targets ET1-sur ET2-sur ET2-seq LN-ET BBi-gel BBi-sol BBi-seq
   bbe-gel bbe-sol bbe-seq AI LN-Th ET1-bas 2.85E-14 2.84E-15 2.84E-15
   2.84E-15 4.49E-20 4.49E-20 4.49E-20 4.49E-20 4.49E-20 4.49E-20 4.49E-20
   4.49E-20 ET2-bas 2.84E-15 3.38E-15 5.06E-09 2.84E-15 4.49E-20 4.49E-20
   4.49E-20 4.49E-20 4.49E-20 4.49E-20 4.49E-20 4.49E-20 LN-ET 2.84E-15
   2.84E-15 2.84E-15 1.12E-09 4.49E-20 4.49E-20 4.49E-20 4.49E-20 4.49E-20
   4.49E-20 4.49E-20 4.49E-20 BBi-bas 4.60E-20 4.60E-20 4.60E-20 4.60E-20
   1.35E-15 2.04E-11 5.15E-09 7.13E-17 7.13E-17 7.13E-17 7.13E-17 7.13E-17
   BBi-sec 4.60E-20 4.60E-20 4.60E-20 4.60E-20 2.74E-09 3.66E-09 9.80E-10
   7.13E-17 7.13E-17 7.13E-17 7.13E-17 7.13E-17 bbe-sec 4.60E-20 4.60E-20
   4.60E-20 4.60E-20 7.13E-17 7.13E-17 7.13E-17 1.97E-09 2.01E-09 9.40E-10
   5.96E-13 7.13E-17 AI 4.60E-20 4.60E-20 4.60E-20 4.60E-20 7.13E-17
   7.13E-17 7.13E-17 7.13E-17 7.13E-17 7.13E-17 1.53E-11 5.67E-16 LN-Th
   4.60E-20 4.60E-20 4.60E-20 4.60E-20 7.13E-17 7.13E-17 7.13E-17 7.13E-17
   7.13E-17 7.13E-17 7.13E-17 1.12E-09 decays 29250 410 15660 128800 603
   16980 1062 2323 12570 660 4621000 444200 S v Sources Targets ET1-sur
   ET2-sur ET2-seq LN-ET BBi-gel BBi-sol BBi-seq bbe-gel bbe-sol bbe-seq
   AI LN-Th ET1-bas 8.34E-10 1.16E-12 4.44E-11 3.66E-10 2.71E-17 7.62E-16
   4.77E-17 1.04E-16 5.64E-16 2.96E-17 2.07E-13 1.99E-14 ET2-bas 8.30E-11
   1.39E-12 7.92E-05 3.66E-10 2.71E-17 7.62E-16 4.77E-17 1.04E-16 5.64E-16
   2.96E-17 2.07E-13 1.99E-14 LN-ET 8.30E-11 1.16E-12 4.44E-11 1.44E-04
   2.71E-17 7.62E-16 4.77E-17 1.04E-16 5.64E-16 2.96E-17 2.07E-13 1.99E-14
   BBi-bas 1.35E-15 1.89E-17 7.21E-16 5.93E-15 8.16E-13 3.46E-07 5.47E-06
   1.66E-13 8.96E-13 4.70E-14 3.30E-10 3.17E-11 BBi-sec 1.35E-15 1.89E-17
   7.21E-16 5.93E-15 1.65E-06 6.21E-05 1.04E-06 1.66E-13 8.96E-13 4.70E-14
   3.30E-10 3.17E-11 bbe-sec 1.35E-15 1.89E-17 7.21E-16 5.93E-15 4.30E-14
   1.21E-12 7.57E-14 4.58E-06 2.52E-05 6.20E-07 2.75E-06 3.17E-11 AI
   1.35E-15 1.89E-17 7.21E-16 5.93E-15 4.30E-14 1.21E-12 7.57E-14 1.66E-13
   8.96E-13 4.70E-14 7.05E-05 2.52E-10 LN-Th 1.35E-15 1.89E-17 7.21E-16
   5.93E-15 4.30E-14 1.21E-12 7.57E-14 1.66E-13 8.96E-13 4.70E-14 3.29E-10
   4.97E-04 SEECAL gives SEE in units of Sv. 84 Equivalent Dose Benchmark
   La Bone Ludep Percent Target (Sv) (Sv) Error ET1-bas 1.25E-09 3.44E-06
   -99.96 ET2-bas 7.92E-05 8.16E-05 -2.89 LN-ET 1.44E-04 1.43E-04 0.70
   BBi-bas 5.81E-06 7.79E-06 -25.37 BBi-sec 6.48E-05 6.70E-05 -3.25
   bbe-sec 3.32E-05 3.51E-05 -5.50 AI 7.05E-05 7.12E-05 -1.02 LN-Th
   4.97E-04 4.90E-04 1.35 85 Detriment Weighted Equivalent Doses HET = HET
   A 1 ET + H 1 ET A 2 ET + H 2 LN A ET LN ET HTH = HBB A sec BB + H sec
   BB A + + + bas BB H bas bb Abb HAI AAI HLN A TH LNTH 86 Detriment
   Weighted Equivalent Dose Benchmark ED DWED Target (Sv) RAF (Sv) Ludep
   Genmod ICRP CD ET1-bas 1.25E-09 0.0010 1.25E-12 ET2-bas 7.92E-05 0.9980
   7.91E-05 LN-ET 1.44E-04 0.0010 1.44E-07 ET 7.92E-05 8.16E-05 7.93E-05
   8.0E-05 BBi-bas 5.81E-06 0.1665 9.68E-07 BBi-sec 6.48E-05 0.1665
   1.08E-05 bbe-sec 3.32E-05 0.3330 1.10E-05 AI 7.05E-05 0.3330 2.35E-05
   LN-TH 4.97E-04 0.0010 4.97E-07 TH 4.68E-05 4.83E-05 4.68E-05 4.7E-05 87
   Effective Dose * HTH (lung dose) is weighted by 0.12 and added to the
   effective dose sum * HET is treated as a remainder organ 88 Systemic
   Biokinetic Models * ICRP 2 (1959) * ICRP 30 series (1979-1988)  Parts
   1, 2, 3, 4, and ICRP 48 * ICRP 56 series (1990-1996)  ICRP 56, 67, 69,
   71, 72 89 ICRP 2 * Based on  stable element distribution in humans  rat
   experimental data  limited human occupational and experimental data *
   Single exponential retention functions for organs * Designed for
   calculating MPCs  concerned with long-term retention  MPC based on
   critical organ  does not address systemic excretion * Mid 1950's
   technology 90 ICRP 2 Plutonium Bone Model 0.9 blood bone 73000 days
   -Ln(2)t 73000 bone q (t) = 0.9e 91 ICRP 30 * Based on  ICRP 2 database
   large mammal/primate experimental data  additional human data *
   Multiple exponential retention functions possible for organs * Designed
   for calculating worker ALIs and DACs  does not address systemic
   excretion  ALI based on dose to all specified organs, not just the
   critical organ * Some physiologically based models (iodine) * Mid
   1970's technology 92 ICRP 30 Plutonium Bone Model 0.45 blood bone 18250
   days -Ln(2)t 18250 bone q (t) = 0.45e 93 ICRP 30 Uranium Bone Model 0.2
   20 days blood 0.023 5000 days bone -Ln(2)t -Ln(2)t 20 5000 bone q (t) =
   0.2e + 0 023 . e 94 ICRP 67 * Multiple exponential retention functions
   for organs * Physiologically based biokinetic models for bone seekers *
   Designed for calculating dose to public and radiation workers *
   Systemic excretion addressed  either explicitly in model or with ff/fu
   ICRP 60 wt for bladder  bioassay * Mid 1980's technology 95 New
   Physiological Models * Bone Surface Seeker  plutonium (ICRP 67)
   neptunium (ICRP 67)  thorium (ICRP 69)  americium (ICRP 67) * Bone
   Volume Seeker  uranium (ICRP 69)  strontium and alkaline earths (ICRP
   67) 96 General Bone Volume Seeker Model ST1 ST0 ST2 liver 2 nonexch
   exch cortical cortical cortical volume volume surface liver 1 nonexch
   exch trabecular plasma trabecular trabecular surface volume volume SI
   other RBC kidney ULI tissue urinary LLI urinary urine bladder path
   contents feces gonads 97 General Bone Surface Seeker Model ST1 ST0 ST2
   liver 2 cortical cortical cortical volume surface marrow liver 1
   trabecular trabecular trabecular blood volume surface marrow SI other
   kidney ULI tissue urinary LLI urinary urine bladder path contents feces
   gonads 98 Advantages of Physiological Biokinetic Models * Realistic
   models * Aid in development of realistic models  extrapolating to human
   subgroups  extrapolating from animals to humans  extrapolating from
   chemical analogs  extrapolating model in time * Realistic treatment of
   daughters  shared kinetics  independent kinetics * Explicit treatment
   of systemic excretion * Evaluate intakes following chelation therapy 99
   Disadvantages of Physiological Biokinetic Models * Complexity * Absence
   of commercially available software  LuDep does not use new systemic
   models  Genmod is in beta test * Acceptance of of new models by
   regulators * Internal dosimetrists' general lack of familiarity with
   the new models 100 Pu-239 Type S Benchmark * Acute inhalation of type S
   5.0 µµm AMAD plutonium-239 under light-work conditions * Comparison of
   results from three sources  MathCad and Excel worksheets with SEECAL
   SEEs  ICRP Database of Dose Coefficients Workers and Members of the
   Public (V1.0 CD)  Genmod-PC V4.13 beta test 101 Mathcad Method *
   Calculate decays  Mathcad worksheet using eigensystem or matrix
   exponential method of solving systems of ODEs. * Create SEE matrix
   SEECAL SEEs in Excel spreadsheet * Multiply decays by SEE matrix * Sum
   doses from all source organ over each target organ. * Sum target doses
   and apply weights to obtain effective dose. 102 SEE Matrix with Decays
   - Left Side SEE UB_Cont C_Bone-S C_Bone-V T_Bone-S T_Bone-V. St_Cont
   SI_Cont ULI_Cont. LLI_Cont Kidneys Liver ET1-sur ET2-sur Adrenals
   4.404E-21 1.550E-19 1.550E-19 3.491E-19 3.491E-19 1.544E-19 3.382E-20
   4.217E-20 1.064E-20 2.562E-18 9.717E-19 3.759E-21 3.759E-21 UB_Wall
   6.920E-13 1.875E-20 1.875E-20 4.357E-20 4.357E-20 9.001E-21 1.197E-19
   8.364E-20 5.207E-19 9.614E-21 5.917E-21 9.305E-23 9.305E-23 Bone_Sur
   4.894E-20 3.437E-11 1.375E-12 3.437E-11 3.437E-12 8.520E-20 2.611E-19
   1.620E-19 4.918E-19 2.315E-19 2.214E-19 2.445E-19 2.445E-19 Brain
   9.104E-24 3.830E-19 3.830E-19 2.493E-19 2.493E-19 2.954E-22 3.952E-23
   4.637E-23 1.895E-23 1.222E-22 4.993E-22 6.661E-20 6.661E-20 Breasts
   7.300E-22 6.208E-20 6.208E-20 1.184E-19 1.184E-19 2.839E-20 3.799E-21
   4.342E-21 1.387E-21 9.684E-21 3.638E-20 1.391E-20 1.391E-20 St_Wall
   9.600E-21 3.192E-20 3.192E-20 6.435E-20 6.435E-20 3.321E-13 3.063E-19
   6.765E-19 9.693E-20 1.479E-19 9.988E-20 2.123E-21 2.123E-21 SI_Wall
   1.132E-19 6.162E-20 6.162E-20 2.238E-19 2.238E-19 1.587E-19 2.076E-13
   7.684E-18 3.890E-18 1.384E-19 1.024E-19 2.907E-22 2.907E-22 ULI_Wall
   8.250E-20 6.235E-20 6.235E-20 2.266E-19 2.266E-19 4.134E-19 1.710E-17
   3.774E-13 2.449E-18 1.224E-19 1.921E-19 5.261E-22 5.261E-22 LLI_Wall
   5.773E-19 1.426E-19 1.426E-19 5.134E-19 5.134E-19 5.607E-20 6.671E-18
   7.861E-19 6.151E-13 2.589E-20 6.684E-21 1.627E-22 1.627E-22 Kidneys
   9.904E-21 5.699E-20 5.699E-20 1.564E-19 1.564E-19 1.500E-19 1.384E-19
   1.136E-19 3.365E-20 5.412E-11 3.515E-19 1.810E-21 1.810E-21 Liver
   5.781E-21 5.007E-20 5.007E-20 9.035E-20 9.035E-20 9.068E-20 1.024E-19
   1.725E-19 8.251E-21 3.515E-19 9.320E-12 4.291E-21 4.291E-21 ET1-bas
   9.259E-23 6.197E-20 6.197E-20 5.315E-20 5.315E-20 1.576E-21 2.907E-22
   5.152E-22 1.972E-22 1.810E-21 4.291E-21 2.851E-14 2.838E-15 ET2-bas
   9.259E-23 6.197E-20 6.197E-20 5.315E-20 5.315E-20 1.576E-21 2.907E-22
   5.152E-22 1.972E-22 1.810E-21 4.291E-21 2.838E-15 3.384E-15 LN-ET
   9.259E-23 6.197E-20 6.197E-20 5.315E-20 5.315E-20 1.576E-21 2.907E-22
   5.152E-22 1.972E-22 1.810E-21 4.291E-21 2.838E-15 2.838E-15 BBi-bas
   6.091E-22 8.574E-20 8.574E-20 1.540E-19 1.540E-19 1.045E-19 6.519E-21
   8.394E-21 2.399E-21 3.524E-20 7.294E-19 4.603E-20 4.603E-20 BBi-sec
   6.091E-22 8.574E-20 8.574E-20 1.540E-19 1.540E-19 1.045E-19 6.519E-21
   8.394E-21 2.399E-21 3.524E-20 7.294E-19 4.603E-20 4.603E-20 bbe-sec
   6.091E-22 8.574E-20 8.574E-20 1.540E-19 1.540E-19 1.045E-19 6.519E-21
   8.394E-21 2.399E-21 3.524E-20 7.294E-19 4.603E-20 4.603E-20 AI
   6.091E-22 8.574E-20 8.574E-20 1.540E-19 1.540E-19 1.045E-19 6.519E-21
   8.394E-21 2.399E-21 3.524E-20 7.294E-19 4.603E-20 4.603E-20 LN-Th
   6.091E-22 8.574E-20 8.574E-20 1.540E-19 1.540E-19 1.045E-19 6.519E-21
   8.394E-21 2.399E-21 3.524E-20 7.294E-19 4.603E-20 4.603E-20 Muscle
   3.680E-19 1.638E-19 1.638E-19 2.229E-19 2.229E-19 2.496E-19 3.395E-19
   2.092E-19 2.862E-19 5.576E-19 2.668E-19 1.009E-18 1.009E-18 Ovaries
   3.645E-19 4.498E-20 4.498E-20 1.576E-19 1.576E-19 2.688E-20 3.779E-18
   3.485E-18 8.600E-18 3.245E-20 1.744E-20 1.914E-22 1.914E-22 Pancreas
   6.790E-21 4.081E-20 4.081E-20 9.323E-20 9.323E-20 3.119E-18 7.026E-20
   8.295E-20 2.330E-20 3.738E-19 4.228E-19 3.534E-21 3.534E-21 R_Marrow
   3.856E-20 2.429E-18 2.429E-18 5.498E-12 5.501E-13 4.748E-20 2.087E-19
   1.343E-19 3.598E-19 1.524E-19 8.720E-20 5.519E-20 5.519E-20 Skin
   3.729E-20 1.425E-19 1.425E-19 1.367E-19 1.367E-19 3.404E-20 1.882E-20
   2.006E-20 4.962E-20 7.483E-20 4.070E-20 4.551E-20 4.551E-20 Spleen
   4.682E-21 4.408E-20 4.408E-20 8.227E-20 8.227E-20 7.368E-19 5.089E-20
   5.138E-20 3.017E-20 2.122E-18 3.413E-20 4.032E-21 4.032E-21 Testes
   2.357E-19 1.930E-20 1.930E-20 1.466E-20 1.466E-20 1.807E-21 1.252E-20
   9.661E-21 8.379E-20 1.862E-21 9.978E-22 2.975E-23 2.975E-23 Thymus
   5.395E-22 6.272E-20 6.272E-20 1.185E-19 1.185E-19 1.737E-20 2.371E-21
   2.943E-21 1.173E-21 8.506E-21 2.878E-20 7.815E-20 7.815E-20 Thyroid
   9.259E-23 6.197E-20 6.197E-20 5.315E-20 5.315E-20 1.576E-21 2.907E-22
   5.152E-22 1.972E-22 1.810E-21 4.291E-21 6.661E-20 6.661E-20 Uterus
   2.309E-18 2.392E-20 2.392E-20 7.576E-20 7.576E-20 2.250E-20 1.374E-18
   2.496E-19 3.486E-19 2.877E-20 1.487E-20 1.777E-22 1.777E-22 Decays
   1.284E+01 1.900E+06 4.332E+05 6.623E+05 3.058E+05 1.708E+03 6.838E+03
   2.224E+04 4.106E+04 7.237E+03 2.070E+06 2.925E+04 4.099E+02 103 SEE
   Matrix with Decays - Right Side ET2-seq LN-ET BBi-gel BBi-sol BBi-seq
   bbe-gel bbe-sol bbe-seq AI LN-Th R_Marrow Testes Blood BT-Soft
   3.759E-21 3.759E-21 3.207E-19 3.207E-19 3.207E-19 3.207E-19 3.207E-19
   3.207E-19 3.207E-19 3.207E-19 3.491E-19 9.583E-22 2.437E-13 2.63E-13
   9.305E-23 9.305E-23 8.325E-22 8.325E-22 8.325E-22 8.325E-22 8.325E-22
   8.325E-22 8.325E-22 8.325E-22 4.357E-20 2.459E-19 2.437E-13 2.63E-13
   2.445E-19 2.445E-19 3.428E-19 3.428E-19 3.428E-19 3.428E-19 3.428E-19
   3.428E-19 3.428E-19 3.428E-19 5.592E-12 4.952E-20 2.437E-13 1.31E-13
   6.661E-20 6.661E-20 3.952E-21 3.952E-21 3.952E-21 3.952E-21 3.952E-21
   3.952E-21 3.952E-21 3.952E-21 2.493E-19 3.035E-24 2.437E-13 2.63E-13
   1.391E-20 1.391E-20 3.317E-19 3.317E-19 3.317E-19 3.317E-19 3.317E-19
   3.317E-19 3.317E-19 3.317E-19 1.184E-19 0.000E+00 2.437E-13 2.63E-13
   2.123E-21 2.123E-21 1.800E-19 1.800E-19 1.800E-19 1.800E-19 1.800E-19
   1.800E-19 1.800E-19 1.800E-19 6.435E-20 2.338E-21 2.437E-13 2.63E-13
   2.907E-22 2.907E-22 6.450E-21 6.450E-21 6.450E-21 6.450E-21 6.450E-21
   6.450E-21 6.450E-21 6.450E-21 2.238E-19 1.252E-20 2.437E-13 2.63E-13
   5.261E-22 5.261E-22 8.396E-21 8.396E-21 8.396E-21 8.396E-21 8.396E-21
   8.396E-21 8.396E-21 8.396E-21 2.266E-19 9.196E-21 2.437E-13 2.63E-13
   1.627E-22 1.627E-22 1.821E-21 1.821E-21 1.821E-21 1.821E-21 1.821E-21
   1.821E-21 1.821E-21 1.821E-21 5.134E-19 1.285E-19 2.437E-13 2.63E-13
   1.810E-21 1.810E-21 3.433E-20 3.433E-20 3.433E-20 3.433E-20 3.433E-20
   3.433E-20 3.433E-20 3.433E-20 1.564E-19 1.862E-21 2.437E-13 2.63E-13
   4.291E-21 4.291E-21 6.592E-19 6.592E-19 6.592E-19 6.592E-19 6.592E-19
   6.592E-19 6.592E-19 6.592E-19 9.035E-20 9.978E-22 2.437E-13 2.63E-13
   2.838E-15 2.838E-15 4.490E-20 4.490E-20 4.490E-20 4.490E-20 4.490E-20
   4.490E-20 4.490E-20 4.490E-20 5.315E-20 2.975E-23 2.437E-13 2.63E-13
   5.060E-09 2.838E-15 4.490E-20 4.490E-20 4.490E-20 4.490E-20 4.490E-20
   4.490E-20 4.490E-20 4.490E-20 5.315E-20 2.975E-23 2.437E-13 2.63E-13
   2.838E-15 1.118E-09 4.490E-20 4.490E-20 4.490E-20 4.490E-20 4.490E-20
   4.490E-20 4.490E-20 4.490E-20 5.315E-20 2.975E-23 2.437E-13 2.63E-13
   4.603E-20 4.603E-20 1.354E-15 2.037E-11 5.148E-09 7.126E-17 7.126E-17
   7.126E-17 7.132E-17 7.126E-17 1.540E-19 2.664E-22 2.437E-13 2.63E-13
   4.603E-20 4.603E-20 2.742E-09 3.659E-09 9.803E-10 7.126E-17 7.126E-17
   7.126E-17 7.131E-17 7.126E-17 1.540E-19 2.664E-22 2.437E-13 2.63E-13
   4.603E-20 4.603E-20 7.126E-17 7.126E-17 7.126E-17 1.972E-09 2.006E-09
   9.398E-10 5.959E-13 7.126E-17 1.540E-19 2.664E-22 2.437E-13 2.63E-13
   4.603E-20 4.603E-20 7.126E-17 7.126E-17 7.126E-17 7.126E-17 7.126E-17
   7.126E-17 1.525E-11 5.674E-16 1.540E-19 2.664E-22 2.437E-13 2.63E-13
   4.603E-20 4.603E-20 7.126E-17 7.126E-17 7.126E-17 7.126E-17 7.126E-17
   7.126E-17 7.126E-17 1.118E-09 1.540E-19 2.664E-22 2.437E-13 2.63E-13
   1.009E-18 1.009E-18 6.737E-19 6.737E-19 6.737E-19 6.737E-19 6.737E-19
   6.737E-19 6.737E-19 6.737E-19 2.229E-19 6.340E-19 2.437E-13 2.63E-13
   1.914E-22 1.914E-22 2.787E-21 2.787E-21 2.787E-21 2.787E-21 2.787E-21
   2.787E-21 2.787E-21 2.787E-21 1.576E-19 0.000E+00 2.437E-13 2.63E-13
   3.534E-21 3.534E-21 1.252E-19 1.252E-19 1.252E-19 1.252E-19 1.252E-19
   1.252E-19 1.252E-19 1.252E-19 9.323E-20 1.465E-21 2.437E-13 2.63E-13
   5.519E-20 5.519E-20 1.339E-19 1.339E-19 1.339E-19 1.339E-19 1.339E-19
   1.339E-19 1.339E-19 1.339E-19 1.118E-11 1.346E-20 2.437E-13 2.63E-13
   4.551E-20 4.551E-20 4.312E-20 4.312E-20 4.312E-20 4.312E-20 4.312E-20
   4.312E-20 4.312E-20 4.312E-20 1.367E-19 1.105E-18 2.437E-13 2.63E-13
   4.032E-21 4.032E-21 3.127E-19 3.127E-19 3.127E-19 3.127E-19 3.127E-19
   3.127E-19 3.127E-19 3.127E-19 8.227E-20 1.279E-21 2.437E-13 2.63E-13
   2.975E-23 2.975E-23 2.662E-22 2.662E-22 2.662E-22 2.662E-22 2.662E-22
   2.662E-22 2.662E-22 2.662E-22 1.466E-20 4.793E-10 2.437E-13 2.63E-13
   7.815E-20 7.815E-20 2.085E-19 2.085E-19 2.085E-19 2.085E-19 2.085E-19
   2.085E-19 2.085E-19 2.085E-19 1.185E-19 1.630E-22 2.437E-13 2.63E-13
   6.661E-20 6.661E-20 4.490E-20 4.490E-20 4.490E-20 4.490E-20 4.490E-20
   4.490E-20 4.490E-20 4.490E-20 5.315E-20 2.975E-23 2.437E-13 2.63E-13
   1.777E-22 1.777E-22 2.158E-21 2.158E-21 2.158E-21 2.158E-21 2.158E-21
   2.158E-21 2.158E-21 2.158E-21 7.576E-20 0.000E+00 2.437E-13 2.63E-13
   1.566E+04 1.288E+05 6.034E+02 1.698E+04 1.062E+03 2.323E+03 1.257E+04
   6.598E+02 4.621E+06 4.442E+05 6.248E+04 2.548E+03 2.648E+03 5.556E+05
   104 Dose Matrix - Left Side Dose UB_Cont C_Bone-S C_Bone-V T_Bone-S
   T_Bone-V. St_Cont SI_Cont ULI_Cont. LLI_Cont Kidneys Liver ET1-sur
   ET2-sur . Adrenals 5.657E-20 2.945E-13 6.714E-14 2.312E-13 1.067E-13
   2.637E-16 2.312E-16 9.379E-16 4.369E-16 1.854E-14 2.011E-12 1.099E-16
   1.541E-18 UB_Wall 8.888E-12 3.563E-14 8.122E-15 2.886E-14 1.332E-14
   1.537E-17 8.185E-16 1.860E-15 2.138E-14 6.958E-17 1.225E-14 2.721E-18
   3.814E-20 Bone_Sur 6.286E-19 6.531E-05 5.956E-07 2.276E-05 1.051E-06
   1.455E-16 1.785E-15 3.603E-15 2.019E-14 1.675E-15 4.583E-13 7.151E-15
   1.002E-16 Brain 1.169E-22 7.278E-13 1.659E-13 1.651E-13 7.623E-14
   5.045E-19 2.702E-19 1.031E-18 7.781E-19 8.844E-19 1.034E-15 1.948E-15
   2.730E-17 Breasts 9.376E-21 1.180E-13 2.689E-14 7.841E-14 3.620E-14
   4.849E-17 2.598E-17 9.657E-17 5.695E-17 7.008E-17 7.531E-14 4.068E-16
   5.702E-18 St_Wall 1.233E-19 6.065E-14 1.383E-14 4.262E-14 1.968E-14
   5.672E-10 2.094E-15 1.505E-14 3.980E-15 1.070E-15 2.067E-13 6.209E-17
   8.702E-19 SI_Wall 1.454E-18 1.171E-13 2.669E-14 1.482E-13 6.843E-14
   2.711E-16 1.419E-09 1.709E-13 1.597E-13 1.002E-15 2.120E-13 8.502E-18
   1.192E-19 ULI_Wall 1.060E-18 1.185E-13 2.701E-14 1.501E-13 6.929E-14
   7.061E-16 1.169E-13 8.394E-09 1.006E-13 8.858E-16 3.976E-13 1.539E-17
   2.157E-19 LLI_Wall 7.415E-18 2.710E-13 6.177E-14 3.400E-13 1.570E-13
   9.577E-17 4.561E-14 1.748E-14 2.526E-08 1.874E-16 1.384E-14 4.758E-18
   6.669E-20 Kidneys 1.272E-19 1.083E-13 2.469E-14 1.036E-13 4.782E-14
   2.562E-16 9.463E-16 2.527E-15 1.382E-15 3.917E-07 7.276E-13 5.294E-17
   7.419E-19 Liver 7.425E-20 9.514E-14 2.169E-14 5.984E-14 2.763E-14
   1.549E-16 7.002E-16 3.837E-15 3.388E-16 2.544E-15 1.929E-05 1.255E-16
   1.759E-18 ET1-bas 1.189E-21 1.178E-13 2.684E-14 3.520E-14 1.625E-14
   2.692E-18 1.988E-18 1.146E-17 8.097E-18 1.310E-17 8.882E-15 8.338E-10
   1.163E-12 ET2-bas 1.189E-21 1.178E-13 2.684E-14 3.520E-14 1.625E-14
   2.692E-18 1.988E-18 1.146E-17 8.097E-18 1.310E-17 8.882E-15 8.300E-11
   1.387E-12 LN-ET 1.189E-21 1.178E-13 2.684E-14 3.520E-14 1.625E-14
   2.692E-18 1.988E-18 1.146E-17 8.097E-18 1.310E-17 8.882E-15 8.300E-11
   1.163E-12 BBi-bas 7.824E-21 1.629E-13 3.714E-14 1.020E-13 4.709E-14
   1.785E-16 4.457E-17 1.867E-16 9.850E-17 2.550E-16 1.510E-12 1.346E-15
   1.887E-17 BBi-sec 7.824E-21 1.629E-13 3.714E-14 1.020E-13 4.709E-14
   1.785E-16 4.457E-17 1.867E-16 9.850E-17 2.550E-16 1.510E-12 1.346E-15
   1.887E-17 bbe-sec 7.824E-21 1.629E-13 3.714E-14 1.020E-13 4.709E-14
   1.785E-16 4.457E-17 1.867E-16 9.850E-17 2.550E-16 1.510E-12 1.346E-15
   1.887E-17 AI 7.824E-21 1.629E-13 3.714E-14 1.020E-13 4.709E-14
   1.785E-16 4.457E-17 1.867E-16 9.850E-17 2.550E-16 1.510E-12 1.346E-15
   1.887E-17 LN-Th 7.824E-21 1.629E-13 3.714E-14 1.020E-13 4.709E-14
   1.785E-16 4.457E-17 1.867E-16 9.850E-17 2.550E-16 1.510E-12 1.346E-15
   1.887E-17 Muscle 4.727E-18 3.112E-13 7.095E-14 1.476E-13 6.816E-14
   4.263E-16 2.321E-15 4.653E-15 1.175E-14 4.035E-15 5.523E-13 2.951E-14
   4.136E-16 Ovaries 4.682E-18 8.547E-14 1.948E-14 1.044E-13 4.819E-14
   4.591E-17 2.584E-14 7.751E-14 3.531E-13 2.348E-16 3.610E-14 5.598E-18
   7.846E-20 Pancreas 8.721E-20 7.754E-14 1.768E-14 6.174E-14 2.851E-14
   5.327E-15 4.804E-16 1.845E-15 9.567E-16 2.705E-15 8.752E-13 1.034E-16
   1.449E-18 R_Marrow 4.953E-19 4.615E-12 1.052E-12 3.641E-06 1.682E-07
   8.109E-17 1.427E-15 2.987E-15 1.477E-14 1.103E-15 1.805E-13 1.614E-15
   2.262E-17 Skin 4.790E-19 2.708E-13 6.172E-14 9.053E-14 4.180E-14
   5.814E-17 1.287E-16 4.462E-16 2.037E-15 5.415E-16 8.425E-14 1.331E-15
   1.865E-17 Spleen 6.014E-20 8.376E-14 1.909E-14 5.448E-14 2.516E-14
   1.258E-15 3.480E-16 1.143E-15 1.239E-15 1.536E-14 7.065E-14 1.179E-16
   1.653E-18 Testes 3.027E-18 3.667E-14 8.360E-15 9.709E-15 4.483E-15
   3.086E-18 8.561E-17 2.149E-16 3.440E-15 1.348E-17 2.065E-15 8.701E-19
   1.219E-20 Thymus 6.930E-21 1.192E-13 2.717E-14 7.848E-14 3.623E-14
   2.967E-17 1.621E-17 6.545E-17 4.816E-17 6.156E-17 5.957E-14 2.286E-15
   3.203E-17 Thyroid 1.189E-21 1.178E-13 2.684E-14 3.520E-14 1.625E-14
   2.692E-18 1.988E-18 1.146E-17 8.097E-18 1.310E-17 8.882E-15 1.948E-15
   2.730E-17 Uterus 2.966E-17 4.545E-14 1.036E-14 5.017E-14 2.316E-14
   3.843E-17 9.395E-15 5.551E-15 1.431E-14 2.082E-16 3.078E-14 5.197E-18
   7.284E-20 105 Dose Matrix - Right Side ET2-seq LN-ET BBi-gel BBi-sol
   BBi-seq . bbe-gel bbe-sol bbe-seq AI LN-Th R_Marrow Testes Blood
   BT-Soft 5.887E-17 4.841E-16 1.935E-16 5.445E-15 3.407E-16 7.450E-16
   4.032E-15 2.116E-16 1.482E-12 1.424E-13 2.181E-14 2.442E-18 6.453E-10
   1.460E-07 1.457E-18 1.198E-17 5.023E-19 1.413E-17 8.843E-19 1.934E-18
   1.047E-17 5.493E-19 3.847E-15 3.698E-16 2.722E-15 6.266E-16 6.453E-10
   1.460E-07 3.829E-15 3.148E-14 2.068E-16 5.820E-15 3.641E-16 7.963E-16
   4.309E-15 2.262E-16 1.584E-12 1.523E-13 3.494E-07 1.262E-16 6.453E-10
   7.301E-08 1.043E-15 8.578E-15 2.385E-18 6.710E-17 4.198E-18 9.181E-18
   4.968E-17 2.608E-18 1.826E-14 1.755E-15 1.558E-14 7.734E-21 6.453E-10
   1.460E-07 2.178E-16 1.791E-15 2.001E-16 5.632E-15 3.523E-16 7.705E-16
   4.170E-15 2.189E-16 1.533E-12 1.473E-13 7.398E-15 0.000E+00 6.453E-10
   1.460E-07 3.325E-17 2.734E-16 1.086E-16 3.056E-15 1.912E-16 4.181E-16
   2.263E-15 1.188E-16 8.317E-13 7.995E-14 4.021E-15 5.958E-18 6.453E-10
   1.460E-07 4.553E-18 3.743E-17 3.892E-18 1.095E-16 6.851E-18 1.498E-17
   8.109E-17 4.256E-18 2.980E-14 2.865E-15 1.398E-14 3.190E-17 6.453E-10
   1.460E-07 8.239E-18 6.775E-17 5.066E-18 1.426E-16 8.919E-18 1.950E-17
   1.055E-16 5.540E-18 3.880E-14 3.729E-15 1.416E-14 2.343E-17 6.453E-10
   1.460E-07 2.548E-18 2.095E-17 1.099E-18 3.092E-17 1.934E-18 4.230E-18
   2.289E-17 1.202E-18 8.414E-15 8.088E-16 3.208E-14 3.275E-16 6.453E-10
   1.460E-07 2.835E-17 2.331E-16 2.071E-17 5.829E-16 3.647E-17 7.975E-17
   4.316E-16 2.265E-17 1.586E-13 1.525E-14 9.772E-15 4.745E-18 6.453E-10
   1.460E-07 6.720E-17 5.526E-16 3.978E-16 1.119E-14 7.002E-16 1.531E-15
   8.287E-15 4.350E-16 3.046E-12 2.928E-13 5.645E-15 2.543E-18 6.453E-10
   1.460E-07 4.445E-11 3.655E-10 2.709E-17 7.623E-16 4.769E-17 1.043E-16
   5.645E-16 2.963E-17 2.075E-13 1.994E-14 3.321E-15 7.581E-20 6.453E-10
   1.460E-07 7.924E-05 3.655E-10 2.709E-17 7.623E-16 4.769E-17 1.043E-16
   5.645E-16 2.963E-17 2.075E-13 1.994E-14 3.321E-15 7.581E-20 6.453E-10
   1.460E-07 4.445E-11 1.440E-04 2.709E-17 7.623E-16 4.769E-17 1.043E-16
   5.645E-16 2.963E-17 2.075E-13 1.994E-14 3.321E-15 7.581E-20 6.453E-10
   1.460E-07 7.209E-16 5.927E-15 8.170E-13 3.459E-07 5.468E-06 1.655E-13
   8.958E-13 4.702E-14 3.296E-10 3.165E-11 9.622E-15 6.789E-19 6.453E-10
   1.460E-07 7.209E-16 5.927E-15 1.655E-06 6.213E-05 1.041E-06 1.655E-13
   8.958E-13 4.702E-14 3.295E-10 3.165E-11 9.622E-15 6.789E-19 6.453E-10
   1.460E-07 7.209E-16 5.927E-15 4.300E-14 1.210E-12 7.570E-14 4.581E-06
   2.522E-05 6.201E-07 2.753E-06 3.165E-11 9.622E-15 6.789E-19 6.453E-10
   1.460E-07 7.209E-16 5.927E-15 4.300E-14 1.210E-12 7.570E-14 1.655E-13
   8.958E-13 4.702E-14 7.047E-05 2.520E-10 9.622E-15 6.789E-19 6.453E-10
   1.460E-07 7.209E-16 5.927E-15 4.300E-14 1.210E-12 7.570E-14 1.655E-13
   8.958E-13 4.702E-14 3.293E-10 4.966E-04 9.622E-15 6.789E-19 6.453E-10
   1.460E-07 1.580E-14 1.299E-13 4.065E-16 1.144E-14 7.156E-16 1.565E-15
   8.469E-15 4.445E-16 3.113E-12 2.992E-13 1.393E-14 1.616E-15 6.453E-10
   1.460E-07 2.997E-18 2.465E-17 1.682E-18 4.732E-17 2.960E-18 6.474E-18
   3.504E-17 1.839E-18 1.288E-14 1.238E-15 9.847E-15 0.000E+00 6.453E-10
   1.460E-07 5.535E-17 4.551E-16 7.554E-17 2.126E-15 1.330E-16 2.908E-16
   1.574E-15 8.261E-17 5.785E-13 5.561E-14 5.825E-15 3.733E-18 6.453E-10
   1.460E-07 8.643E-16 7.107E-15 8.079E-17 2.273E-15 1.422E-16 3.111E-16
   1.683E-15 8.835E-17 6.187E-13 5.947E-14 6.985E-07 3.430E-17 6.453E-10
   1.460E-07 7.127E-16 5.860E-15 2.602E-17 7.321E-16 4.580E-17 1.002E-16
   5.421E-16 2.845E-17 1.992E-13 1.915E-14 8.541E-15 2.816E-15 6.453E-10
   1.460E-07 6.314E-17 5.192E-16 1.887E-16 5.309E-15 3.322E-16 7.264E-16
   3.931E-15 2.063E-16 1.445E-12 1.389E-13 5.140E-15 3.259E-18 6.453E-10
   1.460E-07 4.659E-19 3.831E-18 1.606E-19 4.520E-18 2.828E-19 6.184E-19
   3.346E-18 1.756E-19 1.230E-15 1.182E-16 9.160E-16 1.221E-06 6.453E-10
   1.460E-07 1.224E-15 1.006E-14 1.258E-16 3.540E-15 2.215E-16 4.843E-16
   2.621E-15 1.376E-16 9.634E-13 9.261E-14 7.404E-15 4.154E-19 6.453E-10
   1.460E-07 1.043E-15 8.578E-15 2.709E-17 7.623E-16 4.769E-17 1.043E-16
   5.645E-16 2.963E-17 2.075E-13 1.994E-14 3.321E-15 7.581E-20 6.453E-10
   1.460E-07 2.783E-18 2.288E-17 1.302E-18 3.664E-17 2.292E-18 5.013E-18
   2.713E-17 1.424E-18 9.972E-15 9.585E-16 4.734E-15 0.000E+00 6.453E-10
   1.460E-07 106 Remainder Organs * If the maximum dose to any remainder
   organ is less than the maximum dose to any risk organ, then 10 T m HT T
   = Hremainder = 1 10 Tm T =1 107 Remainder Organs * If the maximum dose
   to a remainder organ T is greater than the maximum dose to the any risk
   organ, then 10 T m HT T = T , 1 T H remainder = 0.5 + 0.5 H 10 T T m T
   = T , 1 T 108 Ht A A x Ht Wt Mass (g) Ht x Mass Ht x Wt Adrenals
   1.467E-07 14 2.053E-06 UB_Wall 1.467E-07 0.050 7.333E-09 Bone_Sur
   9.014E-05 0.010 9.014E-07 Brain 1.467E-07 1400 2.053E-04 Breasts
   1.467E-07 0.050 7.333E-09 St_Wall 1.472E-07 0.120 1.767E-08 S I_W all
   1.481E-07 640 9.477E-05 ULI_Wall 1.551E-07 0.570 8.838E-08 LLI_Wall
   1.719E-07 0.430 7.392E-08 Kidneys 5.383E-07 310 1.669E-04 Liver
   1.944E-05 0.050 9.720E-07 ICRP 60 ET1-bas 1.479E-07 0.001 1.479E-10
   ET2-bas 7.939E-05 0.998 7.923E-05 LN-ET 1.441E-04 0.001 1.441E-07
   BBi-bas 5.960E-06 0.167 9.924E-07 BBi-sec 6.497E-05 0.167 1.082E-05
   bbe-sec 3.332E-05 0.333 1.109E-05 AI 7.062E-05 0.333 2.352E-05 LN-Th
   4.968E-04 0.001 4.968E-07 Muscle 1.467E-07 28000 4.107E-03 Ovaries
   1.467E-07 Pancreas 1.467E-07 100 1.467E-05 R_Marrow 4.655E-06 0.120
   5.586E-07 Skin 1.467E-07 0.010 1.467E-09 S pleen 1.467E-07 180
   2.640E-05 Testes 1.368E-06 0.200 2.736E-07 Thymus 1.467E-07 20
   2.933E-06 Thyroid 1.467E-07 0.050 7.333E-09 Uterus 1.467E-07 80
   1.173E-05 Composite Organs lungs 4.692E-05 0.120 5.630E-06 ET 7.937E-05
   15 colon 1.623E-07 0.120 1.948E-08 oesophagus 1.467E-07 0.050 7.333E-09
   remainder 1.506E-07 0.050 7.528E-09 1.000 30759 4.631E-03 effective
   8.411E-06 109 Dose Benchmark DCF (Sv/Bq) LaBone 8.41E-06 Genmod
   8.41E-06 ICRP 8.30E-06 Genmod uses SEEs from SEECAL 110 ICRP 30 vs ICRP
   66/67: Which is Better? * Neither model gives "right" answer for a
   particular person, but on the average the new models are more "right."
   ICRP 66/67 designed for evaluating bioassay data.  ICRP 66/67 designed
   to be "accurate" instead of "conservative." * ICRP 66/67 is as complex
   as it has to be. 111 Using New Models with Current Regulations * No
   regulations prohibit the use of the new respiratory tract and systemic
   models.  10CFR835 requires the use of ICRP 26 weighting factors.  DACs
   and ALIs are based on ICRP 30. * How to mix new with old  ICRP 2 versus
   ICRP 30 mentality - been there, done that.  No guidance on mixing
   models.  Should I recalculate my historic doses? 112 Ht A A x Ht Wt Ht
   x Wt Adrenals 1.467E-07 UB_Wall 1.467E-07 Bone_Sur 9.014E-05 0.03
   2.704E-06 Brain 1.467E-07 Breasts 1.467E-07 0.15 2.200E-08 St_Wall
   1.472E-07 ICRP 30 SI_Wall 1.481E-07 0.06 8.885E-09 ULI_Wall 1.551E-07
   0.06 9.303E-09 LLI_Wall 1.719E-07 0.06 1.031E-08 Kidneys 5.383E-07 0.06
   3.230E-08 Liver 1.944E-05 0.06 1.166E-06 ET1-bas 1.479E-07 0.001
   1.479E-10 ET2-bas 7.939E-05 0.998 7.923E-05 LN-ET 1.441E-04 0.001
   1.441E-07 BBi-bas 5.960E-06 0.167 9.924E-07 BBi-sec 6.497E-05 0.167
   1.082E-05 bbe-sec 3.332E-05 0.333 1.109E-05 AI 7.062E-05 0.333
   2.352E-05 LN-Th 4.968E-04 0.001 4.968E-07 Muscle 1.467E-07 Ovaries
   1.467E-07 Pancreas 1.467E-07 R_Marrow 4.655E-06 0.12 5.586E-07 Skin
   1.467E-07 Spleen 1.467E-07 Testes 1.368E-06 0.25 3.420E-07 Thymus
   1.467E-07 Thyroid 1.467E-07 0.03 4.400E-09 Uterus 1.467E-07 Composite
   Organs lungs 4.692E-05 0.12 5.630E-06 effective 1.00 1.049E-05 113
   Mixing Models for Plutonium ICRP 30/Jones ICRP 66/Jones Intake Dose
   ICRP 66/67 LAS BZA 114 In-vitro Lung Solubility * Difficult to use with
   ICRP 30 lung model * Readily adapted to F/M/S classifications of ICRP
   66 lung model * Practical application of in-vitro solubility data to
   ICRP 66 lung model discussed in ICRP 71 115 Chelation Therapy * The
   ICRP 67 systemic model explicly considers the plutonium content of the
   bloodstream, including recycling from systemic organs. * This suggests
   a direct and rather simple method for modeling the urinary excretion of
   plutonium following chelation therapy.  Stop biokinetic model at time
   of chelation  Remove plutonium (chelate) that is in the blood
   compartment  Restart biokinetic model with new initial comartment
   contents  Add chelate excretion to normal plutonium excretion 116
   Simplified Model respiratory tract GI tract blood systemic organs
   excreta 117 Initial Contents fraction fraction Compartment 0 days
   Compartment 10 days ET2 3.989E-01 feces 4.000E-01 ET1 3.385E-01 ENV
   3.380E-01 AI2 3.191E-02 TAI2 2.700E-02 AI1 1.596E-02 TAI1 1.100E-02 BB1
   1.171E-02 LIV1 9.000E-03 bb1 6.570E-03 TS 9.000E-03 BB2 5.920E-03 CS
   6.000E-03 AI3 5.320E-03 TAI3 5.000E-03 bb2 4.380E-03 TBB2 4.000E-03
   ETseq 2.000E-04 ST1 4.000E-03 BBseq 1.200E-04 Tbb2 3.000E-03 bbseq
   7.721E-05 LLI 1.000E-03 feces 0.000E+00 blood 1.000E-03 118 Excretion
   Curve 1.E-03 non-chelate chelate 1.E-04 sum 1.E-05 Pu in Urine 1.E-06 0
   10 20 30 40 50 Time After Intake(days) 119 Acknowledgments * Keith
   Eckerman, ORNL * Alan Birchall, NRPB * Tony James, ACJ and Associates *
   Ken Skrable, Retired * Clay French, UML * Gary Mansfield, LLNL *
   Guthrie Miller, LANL 120 Appendicies 1. Listing of Pascal code
   LUNGDEP66 that calculates the deposition fractions for the ICRP 66
   respiratory tract model. 2. Listing of the Mathcad worksheet
   pu239sDecays that calculates the decays that occur following an
   inhalation intake of 5.0 µm AMAD type S Pu-239. 3. Listing of the
   Mathcad worksheet Functions that is called by pu239sDecays. 4. Output
   of Genmod for inhalation intake of 5.0 µm AMAD type S Pu- 239. 5.
   Output of ICRP CD for inhalation intake of 5.0 µm AMAD type S Pu- 239.
   6. Listing of the Mathcad worksheet iodine that illustrates the
   eigensystem and matrix exponential methods of solving systems of
   ordinary differential equations. 1 Appendix 1 { Raises a to the b
   power. } var sign : integer; c : double; begin if (a > 0.0) then rse :=
   sexp(b*ln(a)) else if a = 0.0 then rse := 0 else begin c := trunc(b);
   if b <> c then begin write('error in function rse'); halt; end; if
   odd(trunc(b)) then sign := -1 else sign := 1; rse :=
   sign*sexp(b*ln(abs(a))); end; end; {rse} function log( x:double ) :
   double; { Calculates the common (base 10) logarithm of x. } begin log
   := ln(x) / ln(10.0); end; {log} function alog( x:double ) : double; {
   Calculates 10 raised to the power of x. } begin alog := sexp(x*ln(10));
   end; {alog} function c( d:double ) : double; { Slip correction factor,
   Equation D.6 in ICRP 66. } begin c := 1.0 +
   0.0683/d*(2.514+0.8*sexp(-0.55*d/0.0683)); end; {c} procedure
   calc_diameter( var dt:double; da:double ); { Calculates the
   thermodynamic diameter from the aerodynamic diameter, see Equation D.13
   in ICRP 66. Uses Newton's method to find root. } var new_dt,diff :
   double; function k_0( da,dt:double ) : double; begin k_0 :=
   sqr(dt)*c(dt) - sqr(da)*c(da)*chi/rho; end; function k_1( dt:double ) :
   double; begin k_1 := 0.8*0.0683*sexp(-0.55*dt/0.0683) + 2.0*dt +
   2.514*0.0683 - 0.55*0.8*dt*sexp(-0.55*dt/0.0683); end; begin dt := da;
   repeat new_dt := dt - k_0(da,dt) / k_1(dt); diff := abs(new_dt -
   dt)/new_dt; dt := new_dt; until diff < 1.0e-15; end; {calc_diameter}
   procedure nose_deposition( {$N+} {$R+} program lungdp66; { Calculates
   the deposition in the five regions of the respiratory tract using the
   ICRP 66 respiratory tract model. Written in Turbo Pascal V6.0. T. R. La
   Bone 22 January 1998 } uses wincrt; const chi = 1.5; {particle shape
   factor} rho = 3.0; {density of particle} type depo_record = record eta
   : double; {filtration efficiency for a region} phi : double; {fraction
   of air reaching a region} xi : double; {ratio of phi for two filters}
   DE : double; {deposition in a region} end; depo_type = (ae,th);
   depo_array = array[1..5] of double; var ouf : text; dep : depo_array;
   sum : double; i,j : integer; BB1s, {slow-clearance fraction deposited
   in BB} bb2s, {slow-clearance fraction deposited in bb} amad, {activity
   median aerodynamic diameter} s, {geometric standard deviation of the
   amad} amtd, {activity median thermodynamic diameter} U, {wind speed in
   m/s} V, {total air flow rate through nose and mouth} Vn, {air flow rate
   through the nose} FRC, {functional residual capacity of the lung} VT,
   {tidal volume of the lung} VDet, {anatomical dead space of the ET
   region} VDbb2, {anatomical dead space of the bb region} VDBB1,
   {anatomical dead space of the BB region} SFA, {scaling factor for the
   bronchiole} SFt, {scaling factor for the trachea} SFb : double;
   {scaling factor for the bronchiolar airways} poly_deposition :
   depo_array; {deposition in five regions of RT}
   (**********************************************************************
   ) function sexp( x:double ) : double; { Prevents runtime errors caused
   by exp underflowing. } begin if x < -2000 then sexp := 0.0 else sexp :=
   exp(x); end; function rse( a,b:double ) : double; Appendix 1 R[ae,4] :=
   (0.056+rse(tb2,1.5))*rse(da,rse(tb2,-0.25)); R[ae,5] := Sqr(da)*tA;
   R[ae,6] := (0.056+rse(tb2,1.5))*rse(da,rse(tb2,-0.25)); R[ae,7] :=
   Sqr(da)*V*rse(SFt,3); R[ae,8] := Sqr(da)*Vn*rse(SFt,3); R[ae,9] :=
   Sqr(da)*Vn*rse(SFt,3); R[th,1] := D*rse(Vn*SFt,-0.25); R[th,2] :=
   D*rse(Vn*SFt,-0.25); R[th,3] := D*tB1; R[th,4] := D*tb2; R[th,5] :=
   D*tA; R[th,6] := D*tb2; R[th,7] := D*tB1; R[th,8] :=
   D*rse(Vn*SFt,-0.25); R[th,9] := D*rse(Vn*SFt,-0.25); p[ae,1] := 1.0;
   p[ae,2] := 1.17; p[ae,3] := 1.152; p[ae,4] := 1.173; p[ae,5] := 0.6495;
   p[ae,6] := 1.173; p[ae,7] := 1.152; p[ae,8] := 1.17; p[ae,9] := 1.0;
   p[th,1] := 0.5; p[th,2] := 0.538; p[th,3] := 0.6391; p[th,4] := 0.5676;
   p[th,5] := 0.6101; p[th,6] := 0.5676; p[th,7] := 0.6391; p[th,8] :=
   0.538; p[th,9] := 0.5; { calculate phi, xi, and DE} depo[1].phi := 1.0;
   depo[2].phi := 1.0; depo[3].phi := 1 - VDet/VT; depo[4].phi := 1 -
   (VDet+V_DBB1)/VT; depo[5].phi := 1 - (VDet+V_DBB1+V_Dbb2)/VT;
   depo[6].phi := depo[4].phi; depo[7].phi := depo[3].phi; depo[8].phi :=
   depo[2].phi; depo[9].phi := depo[1].phi; eta[ae,1] :=
   0.5*(1-1/(a[ae,1]*rse(R[ae,1],p[ae,1])+1)); eta[ae,2] :=
   1-1/(a[ae,2]*rse(R[ae,2],p[ae,2])+1); eta[ae,3] := 1 -
   sexp(-a[ae,3]*rse(R[ae,3],p[ae,3])); eta[ae,4] := 1 -
   sexp(-a[ae,4]*rse(R[ae,4],p[ae,4])); eta[ae,5] := 1 -
   sexp(-a[ae,5]*rse(R[ae,5],p[ae,5])); eta[ae,6] := eta[ae,4]; eta[ae,7]
   := 1 - sexp(-a[ae,7]*rse(R[ae,7],p[ae,7])); eta[ae,8] := eta[ae,2];
   eta[ae,9] := eta[ae,1]; eta[th,1] :=
   0.5*(1-sexp(-a[th,1]*rse(R[th,1],p[th,1]))); eta[th,2] := 1 -
   sexp(-a[th,2]*rse(R[th,2],p[th,2])); eta[th,3] := 1 -
   sexp(-a[th,3]*rse(R[th,3],p[th,3])); eta[th,4] := 1 -
   sexp(-a[th,4]*rse(R[th,4],p[th,4])); eta[th,5] := 1 -
   sexp(-a[th,5]*rse(R[th,5],p[th,5])); eta[th,6] := eta[th,4]; eta[th,7]
   := eta[th,3]; eta[th,8] := eta[th,2]; var deposition : depo_array; da,
   dt, U, V, Vn, FRC, VT, VDet, VDbb2, VDBB1, SFA, SFt, SFb : double ); {
   The procedure nose_deposition calculates the deposition in the five
   regions of the respiratory track following an inhalation of a
   monodisperse particulate material through the nose. } var depo :
   array[1..9] of depo_record; eta,a,R,p : array[depo_type,1..9] of
   double; i : integer; V_Dbb2, V_DBB1, D, Psith, tB1, tb2, tA : double;
   begin for i := 1 to 5 do deposition[i] := 0.0; V_Dbb2 := VDbb2 * (1 +
   VT/FRC); V_DBB1 := VDBB1 * (1 + VT/FRC); D := 1.38e-16*310*c(dt) /
   (3*Pi*1.88e-8*dt); Psith := 1 +
   100*sexp(-Sqr(log(100+10/rse(dt,0.9)))); tB1 := VDBB1/V * (1 +
   0.5*VT/FRC); tA := ( VT - VDet - (VDBB1+VDbb2)*(1 + VT/FRC) ) / V; tb2
   := VDbb2/V * (1 + 0.5*VT/FRC); { assign parameters from Table 12 of
   ICRP 66 } a[ae,1] := 3.0e-4; a[ae,2] := 5.5e-5; a[ae,3] := 4.08e-6;
   a[ae,4] := 0.1147; a[ae,5] := 0.146*rse(SFA,0.98); a[ae,6] := 0.1147;
   a[ae,7] := 2.04e-6; a[ae,8] := 5.5e-5; a[ae,9] := 3.0e-4; a[th,1] :=
   18.0; a[th,2] := 15.1; a[th,3] := 22.02*rse(SFt,1.24)*Psith; a[th,4] :=
   -76.8 + 167.0*rse(SFb,0.65); a[th,5] := 170 + 103*rse(SFA,2.13);
   a[th,6] := -76.8 + 167.0*rse(SFb,0.65); a[th,7] :=
   22.02*rse(SFt,1.24)*Psith; a[th,8] := 15.1; a[th,9] := 18.0; R[ae,1] :=
   Sqr(da)*Vn*rse(SFt,3); R[ae,2] := Sqr(da)*Vn*rse(SFt,3); R[ae,3] :=
   Sqr(da)*V*rse(SFt,3); Appendix 1 var lower_limit,upper_limit,increment
   : double; da,dt,fs : double; prob : double; i,j : integer; deposition :
   depo_array; begin BB1s := 0.0; bb2s := 0.0; lower_limit := ln(amad) -
   z*ln(s); upper_limit := ln(amad) + z*ln(s); increment := (upper_limit -
   lower_limit) / number_increments; for i := 1 to 5 do poly_deposition[i]
   := 0.0; for i := 1 to number_increments do begin prob :=
   integral(lower_limit+increment,ln(amad),ln(s)) -
   integral(lower_limit,ln(amad),ln(s)); da := exp(lower_limit +
   increment/2); calc_diameter(dt,da);
   nose_deposition(deposition,da,dt,U,V,Vn,FRC,VT,VDet,VDbb2,VDBB1,SFA,SFt
   ,SFb); for j := 1 to 5 do poly_deposition[j] := poly_deposition[j] +
   prob*deposition[j]; if da <= 2.5*sqrt(rho/chi) then fs := 0.5 else fs
   := 0.5*sexp( -ln(2)/1.1*(dt-2.5)); BB1s := BB1s +
   fs*prob*deposition[3]; bb2s := bb2s + fs*prob*deposition[4];
   lower_limit := lower_limit + increment; end; end; {nose_polydeposition
   } procedure sigma_g( var s:double; amad,amtd:double ); { Calculates the
   geometric standard deviation of a polydisperse aerosol, see Equation 16
   of ICRP 66. } begin if amad > 1.0 then s := 2.5 else if amad < 0.0005
   then s := 1.0 else s := 1 + 1.5*(1- 1/(100*rse(amtd,1.5)+1)); end;
   {sigma_g}
   (**********************************************************************
   ) begin clrscr; {for light exercise} V := 833.0; Vn := V; VT := 1250.0;
   amad := 5.0; U := 0.0; FRC := 3301.0; VDet := 50.0; VDbb2 := 47.0;
   VDBB1 := 49.0; SFA := 1.0; SFt := 1.0; SFb := 1.0; 2 eta[th,9] :=
   eta[th,1]; depo[1].xi := 1.0; for i := 2 to 9 do depo[i].xi :=
   depo[i].phi / depo[i-1].phi; for i := 1 to 9 do { Equation 10}
   depo[i].eta := Sqrt( Sqr(eta[ae,i]) + Sqr(eta[th,i])); depo[1].DE :=
   depo[1].eta { Equation 8} * (1 - 0.5*(1-1/(7.6e-4*rse(da,2.8)+1)) +
   1e-5*rse(U,2.75)*sexp(0.055*da)); for i := 2 to 9 do depo[i].DE :=
   depo[i-1].DE * depo[i].eta * depo[i].xi * (1/depo[i-1].eta - 1);
   depo[1].DE := depo[1].DE + depo[9].DE; depo[2].DE := depo[2].DE +
   depo[8].DE; depo[3].DE := depo[3].DE + depo[7].DE; depo[4].DE :=
   depo[4].DE + depo[6].DE; for i := 1 to 5 do deposition[i] :=
   depo[i].DE; end; {nose_deposition} function integral( x,m,s:double ) :
   double; { Calculates integral of the normal PDF between -infinity and
   x, given x, the mean m, and the standard eviation s. } var p,z,r :
   double; begin z := (x-m)/s; r := 1/(1+0.2316419*abs(z)); p :=
   sexp(-z*z/2) * r*(0.319381530 + r*(-0.356563782 + r*(1.781477937 +
   r*(-1.821255978 + r*1.330274429)))) / sqrt(2*Pi); if z > 0.0 then p :=
   1 - p; integral := p; end; {integral} procedure nose_polydeposition(
   var poly_deposition : depo_array; var BB1s : double; var bb2s : double;
   amad, amtd, s, U, V, Vn, FRC, VT, VDet, VDbb2, VDBB1, SFA, SFt, SFb :
   double ); { The procedure nose_polydeposition calculates the deposition
   in the five regions of the respiratory track following an inhalation of
   a polydisperse particulate material through the nose. } const
   number_increments = 500; z = 4.0; Appendix 1 calc_diameter(amtd,amad);
   sigma_g(s,amad,amtd); for i := 1 to 5 do poly_deposition[i] := 0.0;
   nose_polydeposition(dep,BB1s,bb2s,amad,amtd,s,U,V,Vn,FRC,VT,VDet,VDbb2
   ,VDBB1,SFA,SFt,SFb); for i := 1 to 5 do poly_deposition[i] := dep[i];
   writeln('ET1 : ',(100*poly_deposition[1]):12:2); writeln('ET2 :
   ',(100*poly_deposition[2]):12:2); writeln('BB :
   ',(100*poly_deposition[3]):12:2); writeln('bb :
   ',(100*poly_deposition[4]):12:2); writeln('AI :
   ',(100*poly_deposition[5]):12:2); sum := 0.0; for i := 1 to 5 do sum :=
   sum + poly_deposition[i]; writeln('Sum : ',100*sum:12:2); writeln;
   writeln('Fs BB : ',(BB1s/poly_deposition[3]):12:5); writeln('Fs bb :
   ',(bb2s/poly_deposition[4]):12:5); assign(ouf,'lungdp66.out');
   rewrite(ouf); writeln(ouf,'ET1 : ',(100*poly_deposition[1]):12:2);
   writeln(ouf,'ET2 : ',(100*poly_deposition[2]):12:2); writeln(ouf,'BB :
   ',(100*poly_deposition[3]):12:2); writeln(ouf,'bb :
   ',(100*poly_deposition[4]):12:2); writeln(ouf,'AI :
   ',(100*poly_deposition[5]):12:2); writeln(ouf,'Sum : ',100*sum:12:2);
   writeln(ouf); writeln(ouf,'Fs BB : ',(BB1s/poly_deposition[3]):12:5);
   writeln(ouf,'Fs bb : ',(bb2s/poly_deposition[4]):12:5); close(ouf);
   end. D:\PROJECTS\ABHP Appendix 2 8/14/00 Course\pu239sDecays.mcd Dose
   from an inhalation intake of 5 µµm Type S plutonium-239 using the ICRP
   66 lung model and ICRP 67 systemic model. Written in Mathcad 2000 and
   Excel 97. T. R. La Bone 1.0 Define global variables. ln(2) Radioactive
   decay contstant for Pu-239. (8.7837 106 ) ORIGIN 1 Defines arrays to
   begin with the 1,1 element. T1 0 T2 50 365 Times in days for
   calculating decays. Reference:D:\PROJECTS\ABHP Course\functions.mcd(R)
   2.0 The compartments in the model are assigned numbers to clarify their
   use in the arrays to be defined. Respiratory tract compartments. AI1 :=
   1 bb1 := 4 BB1 := 7 ET2 := 10 LNet := 13 AI2 := 2 bb2 := 5 BB2 := 8
   ETseq := 11 LNth := 14 AI3 := 3 bbseq := 6 BBseq := 9 ET1 := 12
   Transformed respiratory tract compartments. TAI1 := 15 Tbb1 := 18 TBB1
   := 21 TET2 := 24 TLNth := 27 TAI2 := 16 Tbb2 := 19 TBB2 := 22 TETseq :=
   25 TAI3 := 17 Tbbseq := 20 TBBseq := 23 TLNet := 26 GI tract
   compartments and feces. S := 28 SI := 29 ULI := 30 LLI := 31 Systemic
   compartments of the ICRP 67 plutonium model. blood := 32 ST0 := 35 CV
   := 38 TV := 41 OKT := 44 nads := 47 feces := 49 LIV1 := 33 ST1 := 36 CS
   := 39 TS := 42 UP := 45 ENV := 48 urine := 50 LIV2 := 34 ST2 := 37 CM
   := 40 TM := 43 UBC := 46 1 D:\PROJECTS\ABHP Appendix 2 8/14/00
   Course\pu239sDecays.mcd 4.0 Initial content of the compartments for an
   aerosol whose AMAD is defined later in the spreadsheet . Any content
   not explicitly given has a value of zero. AMAD 5 D := Depo(AMAD) i :=
   AI1.. ET1 q0i := Di q0urine := 0 5.0 Define rate constants. All rate
   constants are in units of 1/days. Absorption rate constants Type S
   material in units of 1/days. Defaults are fr=0.001, sr=100, ss=0.0001.
   fr 0.001 sr 100 ss 0.0001 sp := ss + fr (sr - ss) spt := (1 - fr) (sr -
   ss) st := ss sp = 0.10010 spt = 99.89990 st = 0.00010 Define transfer
   rate constants for the respiratory tract compartments.
